Solid Tumours
DDriver 50
An Open Label, Multicenter, Phase 1 Study to Evaluate the Safety, Tolerability, and Pharmacokinetic/Pharmacodynamic Profile of the PARP1 Inhibitor M9466 Alone or in Combination in Participants With Advanced Solid Tumours
Trial overview
Clinical Area
Medical Oncology
Disease
Basket - Solid Tumours
Disease site
Basket
Study Phase
I
Trial Identifiers
Registration number: NCT06421935
GenesisCare Location(s)
Principal Investigator(s)
Clinical trials enquiries